- READ MORE: How women are told they’re depressed or menopausal when actually it’s an underactive thyroid
- See more Daily Mail on Google – save us as a Preferred Source
By LUKE ANDREWS, U.S. SENIOR HEALTH CORRESPONDENT
A major recall of a popular thyroid medication has been issued after inspectors found the pills may not be fully effective.
Major Pharmaceuticals, one of the largest suppliers of generic medicines in the US, issued the alert for its levothyroxine sodium tablets after they were found to contain a ‘subpotent’ dose of the drug.
It means that the pills may not contain as much of the drug as listed on the label, suggesting users could receive a lower dose than prescribed.
The drugs were sold nationwide at major retailers in 10-count blister packs that were available either individually or in cartons containing 100 tablets.
They were available in doses 25, 50, 75, 88, 112 and 150 micrograms and have expiration dates from July 2026 to January 2027.
The FDA said it was a Class II recall, suggesting the drug may cause temporary or medically reversible effects.
No injuries related to the recall have been reported to date.
In previous cases, patients who have medications that have been recalled have been advised to contact their doctor. Patients are advised not to stop taking a medication they have been prescribed without first speaking to their physician.
A major recall has been issued for a thyroid medication.
More than 22 million prescriptions for levothyroxine are written in the US every year, which is used to treat thyroid issues.
Patients who receive the drug include those with hypothyroidism, a condition where the gland does not produce enough of the thyroid hormone, or those suffering from other complications from the gland.